Research payments vs. general payments

The distinction that changes what a large number means.

Open Payments separates records into three types, and conflating them is the fastest way to misread a physician.

General payments

Money or value that goes to the physician: meals, travel, consulting fees, speaking fees, gifts, royalties. This is what people usually mean by “pharma payments”.

Research payments

Funding for a clinical study. Critically, the money usually goes to the institution, not the person. A named physician appears as the principal investigator, but the payment funds trial infrastructure — coordinators, imaging, pharmacy, statistical support, patient reimbursement.

Research figures are frequently in the hundreds of thousands or millions. Presenting one of those as a doctor’s personal income is simply wrong, and it is the single most common error in coverage built on this dataset.

Ownership and investment

Equity or an investment interest held by the physician or an immediate family member. Rare, small in aggregate, and the strongest financial tie in the data because the physician’s wealth moves with the company’s performance.

On this site

DocDollars shows general payments as the headline because that is what the question “what did my doctor receive” means. Research funding is displayed separately and labelled as institution-directed. Ownership interests are flagged explicitly in the characterisation line at the top of the profile.